Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

zoetis belgium sa - sevofluran - bedövningsmedel, allmänt - dogs; cats - för induktion och underhåll av anestesi hos hundar och katter.

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

glaxosmithkline dungarvan limited - esomeprazol - gastroesofageal reflux - proton pump hämmare - nexium control är indicerat för kortvarig behandling av återflödessymtom (t.ex.. halsbränna och syreupprepning) hos vuxna.

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

astrazeneca ab - palivizumab - respiratoriska syncytialvirusinfektioner - immunförsvaret sera och immunglobuliner, - synagis är indicerat för prevention av allvarliga nedre luftvägarna sjukdomar som kräver sjukhusvård orsakad av respiratoriskt syncytialvirus (rsv) hos barn med hög risk för rsv-sjukdom:barn födda på 35 veckor av dräktigheten eller mindre och mindre än sex månaders ålder vid debut av rsv-säsongen;barn som är kortare än två år och som kräver behandling för bronchopulmonary dysplasia inom de senaste sex månader. barn som är kortare än två år och med hemodynamiskt signifikant kongenital hjärtsjukdom.

Շվեդիա - շվեդերեն - Läkemedelsverket (Medical Products Agency)

medartuum ab - sevofluran - inhalationsånga, vätska - sevofluran 1 ml aktiv substans

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artrit, reumatoid - immunsuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - hemorragisk feber, ebola - vacciner - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemorragisk feber, ebola - vacciner - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Շվեդիա - շվեդերեն - Läkemedelsverket (Medical Products Agency)

abbvie ab - foskarbidopa; foslevodopa - infusionsvätska, lösning - 240 mg/ml + 12 mg/ml - foskarbidopa 12 mg aktiv substans; foslevodopa 240 mg aktiv substans

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - atogepant - migrän störningar - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

Եվրոպական Միություն - շվեդերեն - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastiska medel - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.